Does hormone replacement therapy increase the frequency of breast atypical hyperplasia in postmenopausal women? Results from the Bouches du Rhone district screening campaign-Reference-Cited by-同舟云学术

Does hormone replacement therapy increase the frequency of breast atypical hyperplasia in postmenopausal women? Results from the Bouches du Rhone district screening campaign

Published:2003-08 Issue:12 Volume:39 Page:1738-1745
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Gayet A,Estève J,Séradour B,Piana L,Jacquemier J

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Risk factors for breast cancer in women with proliferative breast disease;Dupont;N. Engl. J. Med.,1985

2. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia;Dupont;Cancer,1993

3. A prospective study of benign breast disease and the risk of breast cancer;London;JAMA,1992

4. Histological and biological evolution of human premalignant breast disease;Allred;Endocr. Relat. Cancer,2001

5. Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors;Olsson;Breast Cancer Res. Treat.,1996

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Premalignant Disorders of the Breast in Pregnancy and Lactation;Advances in Experimental Medicine and Biology;2020

2. Hormones, Breast Disorders, and Lactation;Endocrinology;2020

3. Hormones, Breast Disorders, and Lactation;Endocrinology;2020

4. Atypical epithelial hyperplasia of the breast: state of the art;Expert Review of Anticancer Therapy;2016-07-05

5. P4-10-09: Hormone Replacement Therapy: A Benign Breast Disease's Risk?;Poster Session Abstracts;2011-12-15